Factor XIII deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction

Circulation

Volumn 113, Issue 9, 2006, Pages 1196-1202

  Nahrendorf, Matthias ^a,b   Hu, Kai ^a   Frantz, Stefan ^a   Jaffer, Farouc A ^b   Tung, Ching Hsuan ^b   Hiller, Karl Heinz ^a   Voll, Sabine ^a   Nordbeck, Peter ^a   Sosnovik, David ^b   Gattenlöhner, Stefan ^a   Novikov, Mikhail ^b   Dickneite, Gerhard ^c   Reed, Guy L ^d   Jakob, Peter ^a   Rosenzweig, Anthony ^b   Bauer, Wolfgang R ^a   Weissleder, Ralph ^b   Ertl, Georg ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c ZLB Behring   (Germany)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Factor XIII; Healing; Heart failure; Myocardial infarction; Remodeling

Indexed keywords

ALPHA CHEMOKINE; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13 CONCENTRATE; COLLAGEN TYPE 1; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RNA; SCLEROPROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING FACTOR 13 DEFICIENCY; CELL MIGRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; HEART INFARCTION; HEART RUPTURE; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; MALE; MORTALITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; WOUND HEALING; ANIMAL; GENETICS; MOUSE MUTANT; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; EXTRACELLULAR MATRIX PROTEINS; FACTOR XIII; FACTOR XIII DEFICIENCY; HEART RUPTURE, POST-INFARCTION; MICE; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; NEUTROPHILS; VENTRICULAR REMODELING; WOUND HEALING;

EID: 33645521200     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.602094     Document Type: Article

References (27)

1. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003;349:1893-1906.
2. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation. 1993;87:755-763.
3. Muszbek K, Yee VC, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res. 1999;94:271-305.
4. Vanscheidt W, Hasler K, Wokalek H, Niedner R, Schopf E. Factor XIII-deficiency in the blood of venous leg ulcer patients. Acta Derm Venereol. 1991;71:55-57.
5. Inbal A, Lubetsky A, Krapp T, Castel D, Shaish A, Dickneite G, Modis L, Muszbek L, Inbal A. Impaired wound healing in factor XIII deficient mice. Thromb Haemost. 2005;94:432-437.
6. Dardik R, Solomon A, Loscalzo J, Eskaraev R, Bialik A, Goldberg I, Schiby G, Inbal A. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression. Arterioscler Thromb Vasc Biol. 2003;23:1472-1477.
7. Brown LF, Lanir N, McDonagh J, Tognazzi K, Dvorak AM, Dvorak HF. Fibroblast migration in fibrin gel matrices. Am J Pathol. 1993;142:273-283.
8. Paye M, Nusgens BV, Lapiere CM. Factor XIII of blood coagulation modulates collagen biosynthesis by fibroblasts in vitro. Haemostasis. 1989;19:274-283.
9. Lauer P, Metzner HJ, Zettlmeissl G, Li M, Smith AG, Lathe R, Dickneite G. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thromb Haemost. 2002;88:967-974.
10. Jaffer FA, Tung CH, Wykrzykowska JJ, Ho NH, Houng AK, Reed GL, Weissleder R. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi. Circulation. 2004;110:170-176.
11. Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A. Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood. 2003;102:4410-4412.
12. Frantz S, Hu K, Widder J, Bayer B, Witzel CC, Schmidt I, Galuppo P, Strotmann J, Ertl G, Bauersachs J. Peroxisome proliferator activated-receptor agonism and left ventricular remodeling in mice with chronic myocardial infarction. Br J Pharmacol. 2004;141:9-14.
13. Ruff J, Wiesmann F, Hiller KH, Voll S, von Kienlin M, Bauer WR, Rommel E, Neubauer S, Haase A. Magnetic resonance microimaging for noninvasive quantification of myocardial function and mass in the mouse. Magn Reson Med. 1998;40:43-48.
14. Nahrendorf M, Wiesmann F, Hiller KH, Han H, Hu K, Waller C, Ruff J, Haase A, Ertl G, Bauer WR. In vivo assessment of cardiac remodeling after myocardial infarction in rats by cine-magnetic resonance imaging. JCMR. 2000;2:171-180.
15. Akagi A, Tajima S, Ishibashi A, Matsubara Y, Takehana M, Kobayashi S, Yamaguchi N. Type XVI collagen is expressed in factor XIIIa+ monocyte-derived dermal dendrocytes and constitutes a potential substrate for factor XIIIa. J Invest Dermatol. 2002;118:267-274.
16. Tung CH, Ho NH, Zeng Q, Tang Y, Jaffer FA, Reed GL, Weissleder R. Novel factor XIII probes for blood coagulation imaging. Chem Bio Chem. 2003;4:897-899.
17. Tao ZY, Cavasin MA, Yang F, Liu YH, Yang XP. Temporal changes in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarction in mice. Life Sci. 2004;74:1561-1572.
18. Nian L, Lee P, Khaper N, Liu P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543-1553.
19. Niessen HW, Krijnen PA, Visser CA, Meijer CJ, Hack CE. Intercellular adhesion molecule-1 in the heart. Ann N Y Acad Sci. 2002;973:573-585.
20. Chandrasekar B, Smith JB, Freeman GL. Ischemia-reperfusion of rat myocardium activates nuclear factor-κB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation. 2001;103:2296-2302.
21. Altavilla D, Deodato B, Campo GM, Arlotta M, Miano M, Squadrito G, Saitta A, Cucinotta D, Ceccarelli S, Ferlito M, Tringali M, Minutoli L, Caputi AP, Squadrito F. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Cardiovasc Res. 2000;47:515-528.
22. Schaffer CJ, Nanney LB. Cell biology of wound healing. Int Rev Cytol. 1996;169:151-181.
23. Cleutjens JPM, Blankesteijn WM, Daemen MJAP, Smits JFM. The infarcted myocardium: simply dead tissue, or a lively target for therapeutic interventions. Cardiovasc Res. 1999;44:232-241.
24. Chen J, Tung CH, Allport JR, Chen S, Weissleder R, Huang PL. Near-infrared fluorescent imaging of matrix metalloproteinase activity after myocardial infarction. Circulation. 2005;111:1800-1805.
25. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ, Carmeliet P. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med. 1999;5:1135-1142.
26. Bruhn HD, Pohl J. Growth regulation of fibroblasts by thrombin, factor XIII and fibronectin. Klin Wochenschr. 1981;59:145-146.
27. Alkjaersig N, Fletcher AP, Lewis M, Ittyerah R. Reduction of coagulation factor XIII concentration in patients with myocardial infarction, cerebral infarction, and other thromboembolic disorders. Thromb Haemost. 1977;38:863-873.